DZ2074A1 - Formulation nouvelle contenant de la paroxétine, et procédé pour sa préparation. - Google Patents
Formulation nouvelle contenant de la paroxétine, et procédé pour sa préparation.Info
- Publication number
- DZ2074A1 DZ2074A1 DZ960118A DZ960118A DZ2074A1 DZ 2074 A1 DZ2074 A1 DZ 2074A1 DZ 960118 A DZ960118 A DZ 960118A DZ 960118 A DZ960118 A DZ 960118A DZ 2074 A1 DZ2074 A1 DZ 2074A1
- Authority
- DZ
- Algeria
- Prior art keywords
- preparation
- formulation containing
- new formulation
- containing paroxetine
- paroxetine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9514842.5A GB9514842D0 (en) | 1995-07-20 | 1995-07-20 | Novel formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ2074A1 true DZ2074A1 (fr) | 2002-07-22 |
Family
ID=10777960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ960118A DZ2074A1 (fr) | 1995-07-20 | 1996-07-17 | Formulation nouvelle contenant de la paroxétine, et procédé pour sa préparation. |
Country Status (41)
Country | Link |
---|---|
EP (2) | EP0839039B2 (fr) |
JP (2) | JP3922392B2 (fr) |
KR (1) | KR100468351B1 (fr) |
CN (2) | CN1117567C (fr) |
AP (1) | AP1052A (fr) |
AR (1) | AR003463A1 (fr) |
AT (1) | ATE253361T1 (fr) |
AU (1) | AU6659196A (fr) |
BG (1) | BG64076B1 (fr) |
BR (1) | BR9609857A (fr) |
CA (2) | CA2227298C (fr) |
CY (1) | CY2408B1 (fr) |
CZ (1) | CZ294110B6 (fr) |
DE (1) | DE69630603T3 (fr) |
DK (1) | DK0839039T4 (fr) |
DZ (1) | DZ2074A1 (fr) |
EA (2) | EA003508B1 (fr) |
EG (1) | EG23934A (fr) |
ES (1) | ES2208757T5 (fr) |
GB (1) | GB9514842D0 (fr) |
HK (1) | HK1010494A1 (fr) |
HU (1) | HU228853B1 (fr) |
IL (1) | IL122940A0 (fr) |
MA (1) | MA23942A1 (fr) |
MX (1) | MX9800571A (fr) |
MY (1) | MY141373A (fr) |
NO (1) | NO315637B1 (fr) |
NZ (1) | NZ315006A (fr) |
OA (1) | OA10652A (fr) |
PE (1) | PE16098A1 (fr) |
PL (1) | PL184987B1 (fr) |
PT (1) | PT839039E (fr) |
RO (1) | RO119119B1 (fr) |
SI (1) | SI0839039T2 (fr) |
SK (1) | SK284117B6 (fr) |
TR (1) | TR199800077T1 (fr) |
TW (1) | TW464513B (fr) |
UA (1) | UA68328C2 (fr) |
UY (3) | UY24288A1 (fr) |
WO (1) | WO1997003670A1 (fr) |
ZA (1) | ZA966148B (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638948B1 (en) | 1996-09-09 | 2003-10-28 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
US5910319A (en) * | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
WO1998056787A1 (fr) | 1997-06-10 | 1998-12-17 | Synthon B.V. | Composes 4-phenylpiperidine |
US5955475A (en) * | 1997-06-30 | 1999-09-21 | Endo Pharmaceuticals Inc. | Process for manufacturing paroxetine solid dispersions |
EA002482B1 (ru) | 1997-07-01 | 2002-06-27 | Пфайзер Инк. | Соли сертралина и лекарственные формы с длительным высвобождением сертралина |
GB9808479D0 (en) * | 1998-04-22 | 1998-06-17 | Smithkline Beecham Plc | Method of treatment |
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
US6139875A (en) * | 1998-09-29 | 2000-10-31 | Eastman Chemical Company | Aqueous enteric coating composition and low gastric permeability enteric coating |
ATE311883T1 (de) | 1999-03-12 | 2005-12-15 | Aesica Pharmaceuticals Ltd | Stabile pharmazeutische anwendungsform für paroxetin-anhydrat |
IE990406A1 (en) | 1999-05-20 | 2000-12-27 | Elan Corp Plc | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations. |
ATE367153T1 (de) * | 1999-05-20 | 2007-08-15 | Elan Corp Plc | Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme |
ES2159260B1 (es) * | 1999-06-22 | 2002-05-01 | Smithkline Beechan Plc | Nueva composicion de metanosulfonato de paroxetina |
WO2000078290A2 (fr) * | 1999-06-22 | 2000-12-28 | Smithkline Beecham P.L.C. | Nouvelle preparation |
ES2162560B1 (es) * | 1999-06-25 | 2002-07-16 | Rodriguez Concepcion Pena | Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia. |
AR030557A1 (es) | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
US6482440B2 (en) * | 2000-09-21 | 2002-11-19 | Phase 2 Discovery, Inc. | Long acting antidepressant microparticles |
WO2003013480A1 (fr) * | 2001-08-06 | 2003-02-20 | Dr. Reddy's Laboratories Ltd. | Preparation enterique de fluoxetine |
GB2392385A (en) * | 2002-09-02 | 2004-03-03 | Cipla Ltd | Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone |
RU2376988C2 (ru) | 2003-10-29 | 2009-12-27 | Уайт | Фармацевтические композиции замедленного высвобождения, содержащие аплиндор и его производные |
WO2005079756A2 (fr) * | 2004-02-13 | 2005-09-01 | Neuromolecular, Inc. | Methodes et compositions de traitement de troubles psychiatriques |
WO2005107716A1 (fr) * | 2004-03-25 | 2005-11-17 | Cadila Healthcare Limited | Comprimes a liberation lente a base de paroxetine comprenant un noyau et un revetement |
AU2006274565B2 (en) * | 2005-08-02 | 2012-05-17 | Lupin Limited | Novel controlled release compositions of selective serotonin reuptake inhibitors |
KR100591142B1 (ko) * | 2005-11-04 | 2006-06-20 | 지엘팜텍 주식회사 | 파록세틴을 활성물질로 함유하는 장용성 서방형 정제 |
WO2007132344A2 (fr) * | 2006-05-09 | 2007-11-22 | Aurobindo Pharma Limited | Compositions à libération régulée d'un agent antidépresseur |
KR100885029B1 (ko) * | 2007-02-07 | 2009-02-23 | 지엘팜텍 주식회사 | 경구투여용 서방성 삼중정제 |
WO2009006299A2 (fr) * | 2007-06-29 | 2009-01-08 | Dr. Reddy's Laboratories Ltd. | Systèmes à multiples particules |
CA2698808A1 (fr) | 2007-09-13 | 2009-03-19 | Concert Pharmaceuticals, Inc. | Synthese de benzo[d][1,3]dioxoles et de catechols deuteries, ainsi que de leurs derives |
TW201010743A (en) * | 2008-09-05 | 2010-03-16 | Otsuka Pharma Co Ltd | Pharmaceutical solid preparation |
UA105057C2 (uk) * | 2009-08-24 | 2014-04-10 | Х. Луннбек А/С | Композиція 1-[2-(2,4-диметилфенілсульфаніл)феніл]-піперазину |
CN103371982A (zh) * | 2012-04-20 | 2013-10-30 | 王进京 | 盐酸帕罗西汀肠溶控释片新型处方组成及制备方法 |
WO2014009152A1 (fr) * | 2012-07-09 | 2014-01-16 | Unilever N.V. | Composition de soins d'hygiène personnelle à effet photoprotecteur |
CN103550182B (zh) * | 2013-10-29 | 2015-04-08 | 吉林省东盟制药有限公司 | 一种肠溶缓释组合物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8626936D0 (en) * | 1986-11-11 | 1986-12-10 | Ferrosan As | Treatment |
MC2025A1 (fr) * | 1988-04-20 | 1990-04-25 | Asta Pharma Ag | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee |
IT1237904B (it) * | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
JPH0436237A (ja) * | 1990-06-01 | 1992-02-06 | Taiho Yakuhin Kogyo Kk | 抗腫瘍性複合製剤 |
DK0497956T3 (da) * | 1990-08-21 | 1996-08-12 | Theratech Inc | Præparater med reguleret frigivelse |
JPH06502854A (ja) * | 1990-11-24 | 1994-03-31 | ビーチャム・グループ・パブリック・リミテッド・カンパニー | 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用 |
HUT69390A (en) * | 1991-05-07 | 1995-09-28 | Dynagen Inc | Controlled, sustained release delivery system for smoking cessation |
JPH05139964A (ja) * | 1991-11-14 | 1993-06-08 | Takada Seiyaku Kk | 塩酸メキシレチン腸溶性製剤 |
ATE212224T1 (de) * | 1993-11-23 | 2002-02-15 | Euro Celtique Sa | Verfahren zur herstellung einer arzneizusammensetzung mit verzögerter wirkstoffabgabe |
IT1274241B (it) * | 1993-12-03 | 1997-07-15 | Smithkline Beecham Farma | Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono |
CA2143070C (fr) * | 1994-02-22 | 2001-12-18 | Pankaj Modi | Formulation pharmaceutique sous forme de suspension liquide administree par voie orale, pour degagement prolonge |
GB9422154D0 (en) * | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
MX9707585A (es) * | 1995-04-03 | 1997-12-31 | Abbott Lab | Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada. |
-
1995
- 1995-07-20 GB GBGB9514842.5A patent/GB9514842D0/en active Pending
-
1996
- 1996-07-17 DZ DZ960118A patent/DZ2074A1/fr active
- 1996-07-18 AR ARP960103639A patent/AR003463A1/es not_active Application Discontinuation
- 1996-07-18 MA MA24317A patent/MA23942A1/fr unknown
- 1996-07-18 MY MYPI96002956A patent/MY141373A/en unknown
- 1996-07-18 EG EG68296A patent/EG23934A/xx active
- 1996-07-19 ES ES96926388T patent/ES2208757T5/es not_active Expired - Lifetime
- 1996-07-19 TR TR1998/00077T patent/TR199800077T1/xx unknown
- 1996-07-19 UY UY24288A patent/UY24288A1/es not_active IP Right Cessation
- 1996-07-19 EA EA200100022A patent/EA003508B1/ru not_active IP Right Cessation
- 1996-07-19 CA CA002227298A patent/CA2227298C/fr not_active Expired - Lifetime
- 1996-07-19 EP EP96926388A patent/EP0839039B2/fr not_active Expired - Lifetime
- 1996-07-19 CA CA002445678A patent/CA2445678C/fr not_active Expired - Lifetime
- 1996-07-19 PE PE1996000548A patent/PE16098A1/es not_active IP Right Cessation
- 1996-07-19 NZ NZ315006A patent/NZ315006A/xx not_active IP Right Cessation
- 1996-07-19 KR KR10-1998-0700380A patent/KR100468351B1/ko not_active IP Right Cessation
- 1996-07-19 DK DK96926388T patent/DK0839039T4/da active
- 1996-07-19 MX MX9800571A patent/MX9800571A/es active IP Right Grant
- 1996-07-19 AT AT96926388T patent/ATE253361T1/de active
- 1996-07-19 EP EP03078259A patent/EP1382337A1/fr not_active Withdrawn
- 1996-07-19 HU HU9900299A patent/HU228853B1/hu unknown
- 1996-07-19 ZA ZA9606148A patent/ZA966148B/xx unknown
- 1996-07-19 BR BR9609857A patent/BR9609857A/pt not_active Application Discontinuation
- 1996-07-19 DE DE69630603T patent/DE69630603T3/de not_active Expired - Lifetime
- 1996-07-19 AU AU66591/96A patent/AU6659196A/en not_active Abandoned
- 1996-07-19 SI SI9630661T patent/SI0839039T2/sl unknown
- 1996-07-19 AP APAP/P/1998/001177A patent/AP1052A/en active
- 1996-07-19 RO RO98-00082A patent/RO119119B1/ro unknown
- 1996-07-19 PT PT96926388T patent/PT839039E/pt unknown
- 1996-07-19 SK SK53-98A patent/SK284117B6/sk not_active IP Right Cessation
- 1996-07-19 TW TW085108758A patent/TW464513B/zh not_active IP Right Cessation
- 1996-07-19 UA UA98010283A patent/UA68328C2/uk unknown
- 1996-07-19 WO PCT/EP1996/003252 patent/WO1997003670A1/fr active IP Right Grant
- 1996-07-19 CZ CZ1998183A patent/CZ294110B6/cs not_active IP Right Cessation
- 1996-07-19 EA EA199800140A patent/EA003775B1/ru not_active IP Right Cessation
- 1996-07-19 PL PL96324553A patent/PL184987B1/pl unknown
- 1996-07-19 IL IL12294096A patent/IL122940A0/xx not_active IP Right Cessation
- 1996-07-19 JP JP50632597A patent/JP3922392B2/ja not_active Expired - Lifetime
- 1996-07-19 CN CN96196819A patent/CN1117567C/zh not_active Expired - Lifetime
- 1996-07-19 CN CNB031490468A patent/CN1282456C/zh not_active Expired - Lifetime
-
1997
- 1997-01-10 UY UY24436A patent/UY24436A1/es not_active IP Right Cessation
-
1998
- 1998-01-19 NO NO19980240A patent/NO315637B1/no not_active IP Right Cessation
- 1998-01-20 OA OA9800005A patent/OA10652A/en unknown
- 1998-02-17 BG BG102259A patent/BG64076B1/bg unknown
- 1998-11-06 HK HK98111807A patent/HK1010494A1/xx not_active IP Right Cessation
-
2000
- 2000-07-13 UY UY26242A patent/UY26242A1/es not_active Application Discontinuation
-
2004
- 2004-03-15 CY CY0400019A patent/CY2408B1/xx unknown
-
2006
- 2006-04-27 JP JP2006123731A patent/JP2006265258A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2074A1 (fr) | Formulation nouvelle contenant de la paroxétine, et procédé pour sa préparation. | |
DZ2114A1 (fr) | Procédé pour la préparation du d-tartrate de (-)-cis-6(s)-phényl-5}4-(2-pyrrolidine-1-ylethoxy)-phénylÜ-5,6,7,8-tétrahydronaphtalène-2-ol. | |
DZ2045A1 (fr) | Amides thérapeutiques, procédé pour leur préparation et compositions les contenant. | |
DZ2890A1 (fr) | 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2300A1 (fr) | Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2299A1 (fr) | Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
CH689805A8 (fr) | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. | |
DZ2197A1 (fr) | Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
MA26415A1 (fr) | Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant | |
DZ2128A1 (fr) | Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
MA23831A1 (fr) | Derives de quinazoline, procede pour leur preparation et composition les contenant | |
MA26430A1 (fr) | 4 (3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
CY2537B1 (fr) | Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
MA26432A1 (fr) | Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
DZ1957A1 (fr) | Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
FR2740136B1 (fr) | Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant | |
FR2718136B1 (fr) | Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant. | |
DZ2217A1 (fr) | Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant. | |
DZ2083A1 (fr) | Trihydrate de méthanesulfonate de (1s,2s)-1-(4-hydroxyphényl)-2-(4-hydroxy-4-phénylpipéridine-1-yl)-1-propanol, procédé pour sa préparation et composition pharmaceutique le contenant. | |
MA26433A1 (fr) | Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26581A1 (fr) | Forme hydratee nouvelle d'un derive de thiazolidine-dione, procede pour sa preparation et composition pharmaceutique la contenant | |
HUP9901065A3 (en) | New barbituric acid derivatives, pharmaceutical compositions containing these compounds and process for producing them | |
DZ2155A1 (fr) | Aazétidines, procédé pour leur préparation, et co mpositions pharmaceutiques les contenant. | |
DZ2044A1 (fr) | 5,6-Dihydro-9h-pyrazolo Ä3,4-cÜ-1,2,4-triazol Ä4,3-alphaÜpyridines tricycliques procédé pour leur préparation et compositions les contenant. | |
MA26582A1 (fr) | Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant |